Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)The complicated relationship between attention deficit/hyperactivity disorder and substance use disordersCo-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs.Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders.Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?Male adolescent substance use disorder and attention-deficit hyperactivity disorder: a review of the literature.Multidimensional Predictors of Treatment Outcome in Usual Care for Adolescent Conduct Problems and Substance Use.Implementing substance abuse group therapy clinical trials in real-world settings: challenges and strategies for participant recruitment and therapist training in the Women's Recovery Group Study.Treating Mental Health and Substance Use Disorders in Adolescents: What Is on the Menu?Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.Moderators of Brief Motivation-Enhancing Treatments for Alcohol-Positive Adolescents Presenting to the Emergency Department.Do Stimulants Reduce the Risk for Alcohol and Substance Use in Youth With ADHD? A Secondary Analysis of a Prospective, 24-Month Open-Label Study of Osmotic-Release Methylphenidate.One-year abstinence improves ADHD symptoms among patients with polysubstance use disorder.International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
P2860
Q22061981-D5654EE3-DF8D-4EAD-B96C-55B5F89F34DFQ26851607-B020A62D-AB72-40A3-9DE6-AC1C0401F237Q33919558-61685FFC-F685-4976-8951-6DBB7E81C824Q33919571-E7E5F1B9-2F18-4691-B5EF-DF8952E3678CQ33919950-2AD78F04-E501-41CA-AE19-4E6466A4F4F1Q35490379-A8203EF3-0B2B-46D8-85D7-634F472ECBB5Q37180507-F209BEB1-9CCF-4A7B-8CEA-00C64F2A1DCFQ37702885-EE21F644-58F4-4BD5-A545-FFD54A5EB63BQ38766157-7B53DA5E-7AF9-44F6-B988-EEEFA3DD1B38Q39043925-65D6BB2F-5373-44C7-A072-0ADD2DC2B7C1Q40400747-AB62EFD8-C342-4796-A140-EB926015F862Q42681997-06FC8148-3F8B-4CCE-BCE7-8D94077F0A34Q49744162-C400FF65-2E6F-476E-BE06-1CA5139FA2A0Q55339438-C958B69C-B155-4B3C-A3D7-F63307272F37
P2860
Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Predictors of treatment respon ...... eficit/hyperactivity disorder.
@ast
Predictors of treatment respon ...... eficit/hyperactivity disorder.
@en
type
label
Predictors of treatment respon ...... eficit/hyperactivity disorder.
@ast
Predictors of treatment respon ...... eficit/hyperactivity disorder.
@en
prefLabel
Predictors of treatment respon ...... eficit/hyperactivity disorder.
@ast
Predictors of treatment respon ...... eficit/hyperactivity disorder.
@en
P2093
P2860
P50
P1476
Predictors of treatment respon ...... deficit/hyperactivity disorder
@en
P2093
Genie Bailey
Kathlene Trello-Rishel
Paul A Nakonezny
Paula Riggs
P2860
P304
P356
10.1016/J.JSAT.2012.07.001
P577
2012-08-11T00:00:00Z